Delivery Order SPE2DB24D1104-SPE2DB25FXVR7

Award Date 12/17/24
Potential Completion Date 12/18/24
Potential Value $1.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
  • SPE2DB24D1104
    Indefinite Delivery Contract
  • SPE2DB24D1104-SPE2DB25FXVR7
    Delivery Order

This federal contract award, valued at $1,461.75, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of APREPITANT 40 MG CAPSULE UD 5S, a pharmaceutical product. This award is not designated as a set-aside contract.

The contract has an ultimate completion date of December 18, 2024 and was awarded on December 17, 2024. AmerisourceBergen Drug Corp, as the prime contractor, will be responsible for delivering the pharmaceutical product to support military healthcare programs and other federal medical institutions served by the DLA. This contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to the agency. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000, for similar medical products and prescription drugs.

Generated 3/18/25, 9:51 AM